Pharmacokinetic and metabolomic studies with a BIO 300 Oral Powder formulation in nonhuman primates

BIO 300, a pharmaceutical formulation of genistein, is being developed as a radiation countermeasure to treat hematopoietic acute radiation syndrome (H-ARS) and the delayed effects of acute radiation exposure (DEARE). Several studies have affirmed its safety and efficacy in alleviating the damaging...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yaoxiang, Girgis, Michael, Jayatilake, Meth, Serebrenik, Artur A., Cheema, Amrita K., Kaytor, Michael D., Singh, Vijay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356050/
https://www.ncbi.nlm.nih.gov/pubmed/35931769
http://dx.doi.org/10.1038/s41598-022-17807-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356050/
https://www.ncbi.nlm.nih.gov/pubmed/35931769
http://dx.doi.org/10.1038/s41598-022-17807-7

Ejemplares similares